# UNLOXCYT

NDC: 70095-130
Generic name: cosibelimab
Labeler / Manufacturer: Sun Pharmaceutical Industries, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20251208

FDA application: BLA761297

## Active ingredients

- COSIBELIMAB: 300 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70095-130"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70095-130
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=06bdadd5-d2db-406f-a3f8-de47f48a52e3